News & Analysis

Russia/Ukraine Crisis: U.K. and E.U. Impose Further Sanctions (June 16, 2022)
China’s NMPA Proposes Implementing Regulations for the Drug Administration Law (May 13, 2022)
Russia/Ukraine Crisis: U.S. Sanctions and Export Controls Escalation Continues (May 9, 2022)
Latest Updates to UK and EU Sanctions (April 15, 2022)
Latest Updates to UK and EU Sanctions Related to Russia and Belarus (March 31, 2022)
Podcast: On the Ropes: Enforcement Risk Roundtable—Anti-Corruption and International Risk Perspectives from Recent Developments in Sweden (March 15, 2022)
Russia/Ukraine Crisis: Latest Round of U.S. Sanctions (March 14, 2022)
Russia/Ukraine Crisis: The Latest International Sanctions Response (March 3, 2022)
UK unveils draft Economic Crime (Transparency and Enforcement) Bill (March 2, 2022)
Russia/Ukraine Crisis: The Evolving International Sanctions Response (February 23, 2022)
Ropes & Gray Attorneys Author Mandatory Human Rights Due Diligence Legislation Guidance for Companies and Suppliers (December 17, 2021)
United States Strategy on Countering Corruption (December 8, 2021)
Podcast: Health Care Compliance Check-up: Belgium (November 18, 2021)
Podcast: Health Care Compliance Check-up: Mexico (October 18, 2021)
Podcast: Health Care Compliance Check-up: Netherlands (September 8, 2021)
Podcast: Health Care Compliance Check-up: Brazil (August 5, 2021)
Podcast: Health Care Compliance Check-up: Czech Republic (July 1, 2021)
In Law360, Health Care Attorneys Examine Compliance Considerations for Pharmaceutical Testing Programs (June 8, 2021)
Corporate Criminal Liability for Corruption in Malaysia – Taking Action (May 5, 2021)
Evolution of UK Enforcement Strategies in OFSI Updated Monetary Penalty Guidance for Financial Sanctions Breaches (April 16, 2021)
Podcast: On the Ropes: Enforcement Risk Roundtable—Anti-Corruption and International Risk Perspectives from Recent Developments in Poland (April 15, 2021)
Chinese Government Introduces Rules Restricting Application of Foreign Laws (February 17, 2021)
Podcast: R&G Insights Lab – Culture & Compliance Chronicles: Compliance Analytics Simplified (A Chat with Integrity Tech Leaders from Lextegrity, Part II) (January 27, 2021)
Indonesia – A Practical Approach to Security Threats (January 15, 2021)
Podcast: 2021 Global Anti-Corruption Update (January 14, 2021)
COVID-19 Podcast: Global Health Care Compliance: Managing Compliance Issues and Process Changes Related to the Pandemic (June 4, 2020)
The FCA’s continued focus on behavioural science and data-analytics (November 21, 2019)
Building a “Healthy China” Through Innovation and Compliance (September 20, 2019)
In Food and Drug Law Journal, Health Care Attorneys Examine India’s Final Clinical Trial Rules (August 29, 2019)
GDPR: One Year On (July 9, 2019)
A Guide to FCA Cooperation Credit for Life Sciences Companies (June 27, 2019)
In Asia-Pacific Biotech News, Life Sciences Partner Addresses Proposed China Pharmaceutical Regulatory Changes (June 14, 2019)
China’s State Council Publishes New Regulations on the Management of Human Genetic Resources (June 14, 2019)
Managing Corruption Risks Facing Healthcare Companies in Eastern Europe (June 12, 2019)
In Pink Sheet, Life Sciences Partner Examines Proposed Revision to China’s Drug Administration Law (May 23, 2019)
In Bio-IT World, Attorneys Address ROI of Health Care Compliance (May 16, 2019)
China Proposes Major Changes to Pharmaceutical Regulations (May 15, 2019)
New DOJ Guidance Reflects an Evolution in the Evaluation of Corporate Compliance Programs (May 2, 2019)
In CenterWatch, Health Care Attorney Discusses GDPR Impact on Clinical Research (April 10, 2019)
Catnip for Whistleblowers: The Status of SOX Whistleblower Protections in FCPA Cases (March 27, 2019)
FCPA Corporate Enforcement Policy Update: DOJ Introduces New Compliance Requirements for Companies Using Instant Messaging Platforms (March 21, 2019)
New International Pharmaceutical Practice Code Tightens Restrictions on Gifts (February 27, 2019)
World Bank Group Debars Brazil-Based Odebrecht Subsidiary Amid Allegations of Fraudulent and Collusive Practices (February 1, 2019)
China Aims to Introduce Routine Drug and Device Overseas Inspections (January 14, 2019)
Health Care Attorneys Author Article on Evolving Regulatory Landscape for Clinical Trials in India (December 3, 2018)
Health Care Partner Co-Authors Article on Clinical Trial Enterprise in India (October 31, 2018)
China’s Health Authorities Issue New Rules on Telemedicine (September 26, 2018)
Bid Rigging: For Multinationals, More Than Just a Local Law Violation (September 5, 2018)
Key Amendment to India’s Anti-Corruption Legislation Has Significant Implications for Multinationals Doing Business in India (August 21, 2018)
In Law360, Global Team Examines How Distributors Expose Health and Life Sciences Companies to FCPA Risks (August 15, 2018)
The Impact of Scientific Data Administrative Measures on Foreign Companies in China (August 13, 2018)
Podcast: International Risks Facing Companies in Latin America (August 13, 2018)
Implications of Distributor Misconduct for Global Health Care and Life Sciences Companies (August 2, 2018)
China's New Medical Device Regulations Bring Big Changes (July 26, 2018)
China’s MOJ Solicits Comments on Amendment to Medical Device Regulations (June 29, 2018)
Ropes & Gray Partner Amanda Raad Hosted a Panel on Sexual Misconduct in the Work Place during 2018 Women Leaders in Life Sciences Law Conference (June 20, 2018)
Podcast: Common Risks and Challenges in Running a Global Ethics & Compliance Program (June 19, 2018)
GDPR is here: the dawning of a new era? (May 25, 2018)
"Creating a successful global compliance programme," PMLiVE.com (May 10, 2018)
The China Drug Administration Proposes a Working Procedure for Pharmaceutical Study Data Protection (May 8, 2018)
De-Implementation Day: Preparing for Changes to U.S. Sanctions Targeting Iran (May 2, 2018)
Podcast - Risk Management: Troubleshooting & Problem Solving (April 23, 2018)
What Companies Need to Know About China’s New Market Regulator (April 13, 2018)
Podcast - Risk Management: Bringing a Compliance Program to Life (April 10, 2018)
Health Care Attorneys Examine India’s Draft Clinical Trial Rules (April 4, 2018)
China’s New State Administration for Market Regulation: What to Know and What to Expect (April 3, 2018)
Spotlight on Korea (March 28, 2018)
GDPR – No Notification Fees, But UK Regulator to Implement New “Data Protection” Fees (March 1, 2018)
“Risky business for pharma,” Pharmaceutical Market Europe (February 8, 2018)
Video -Complying with EU GDPR Requirements in Clinical Trials (February 6, 2018)
Globalizing Your Compliance Program (January 29, 2018)
New Draft Guidelines on GDPR Consent Requirement’s Application to Scientific Research (January 19, 2018)
Video - Legal Risk Management Forum (November 21, 2017)
The UK’s Data Protection Authority goes myth-busting: fining powers; consent; the "misconception" that the GDPR is an unnecessary burden; and data breach reporting (October 24, 2017)
China, Brazil and Russia Named by Healthcare Companies as Riskiest Markets for Compliance and Regulation (October 23, 2017)
Cross-Office Team Authors Law360 Article on How Conduct Abroad Can Impact U.S. Health Care Business (October 13, 2017)
Shanghai Tightens Industry Interactions with HCPs (October 11, 2017)
Unintended Consequences: Ex-U.S. Activities Impacting U.S. Federal Health Care Business (October 4, 2017)
Reconciling Personal Data Consent Practices in Clinical Trials with the EU General Data Protection Regulation (September 20, 2017)
Australia Proposes Modern Slavery Reporting Requirements for Multinationals – An Overview and Comparison to Existing Corporate Modern Slavery Disclosure Legislation (September 20, 2017)
The EU Conflict Minerals Regulation – Frequently Asked Questions and Take-Aways for Downstream Companies (or Why Should I Care About Yet Another New Supply Chain Regulation?) (September 6, 2017)
Excessive Pricing in Generic Drug Markets (August 23, 2017)
UK Government Sets Forth Approach for GDPR (August 23, 2017)
Privacy Shield dented? The EU Parliament’s Civil Liberties, Justice and Home Affairs Committee identifies deficiencies in US implementation of the Privacy Shield (August 9, 2017)
Protecting Privilege in the U.S. and the U.K. After ENRC (June 29, 2017)
South Korea Fines Prominent Pharmaceutical Manufacturer in Latest Anti-Corruption Enforcement Efforts (May 1, 2017)
“Using Biospecimens Collected Abroad in Future Research: Key Considerations,” Bloomberg BNA’s Medical Research Law & Policy Report (April 19, 2017)
Evaluating the FCPA Pilot Program: The Data, The Trends (April 19, 2017)
“Thoughts on EU’s Draft E-Privacy Regulation,” Law360 (April 10, 2017)
“Helping piece together the life sciences puzzle,” Chicago Daily Law Bulletin (April 3, 2017)
A Judicial Reinterpretation of the Brazilian Constitution’s Right to Health Care (March 30, 2017)
“How The GDPR Will Impact Life Sciences And Health Care,” Law360 (February 21, 2017)
Hot Topics in Supply Chain Compliance (January 24, 2017)
Update on the Anti-Corruption Landscape in Mexico (December 20, 2016)
Recent Developments in Japanese Enforcement of Foreign Bribery Laws (November 16, 2016)

Cookie Settings